Aptus Pharma Limited (BOM:544529)

Aptus Pharma Revenue

In the fiscal year ending March 31, 2026, Aptus Pharma had annual revenue of 465.75M INR with 89.65% growth. Aptus Pharma had revenue of 321.97M in the half year ending March 31, 2026.

• Revenue: 465.75M
• Revenue Growth: +89.65%
• P/S Ratio: 7.52
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	465.75M	220.17M	89.65%
Mar 31, 2025	245.58M	67.01M	37.52%
Mar 31, 2024	178.57M	39.60M	28.49%
Mar 31, 2023	138.97M	33.91M	32.27%
Mar 31, 2022	105.07M	54.11M	106.18%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 30, 2026

Data Sources Report a data error